1. Home
  2. XCUR

as of 02-10-2026 1:08pm EST

$4.39
+$0.08
+1.86%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Founded: 2011 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 26.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 48.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.72 EPS Growth: N/A
52 Week Low/High: $3.10 - $15.91 Next Earning Date: 03-17-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: -8467000.0 FCF Growth: N/A

Stock Insider Trading Activity of Exicure Inc. (XCUR)

Sell
XCUR Jan 21, 2026

Avg Cost/Share

$4.50

Shares

258,367

Total Value

$1,162,651.50

Owned After

1,598,947

SEC Form 4

Sell
XCUR Jan 16, 2026

Avg Cost/Share

$4.50

Shares

734,747

Total Value

$3,306,361.50

Owned After

1,598,947

SEC Form 4

Sell
XCUR Jan 7, 2026

Avg Cost/Share

$4.50

Shares

741,272

Total Value

$3,335,724.00

Owned After

1,598,947

SEC Form 4

XCUR Dec 8, 2025

Avg Cost/Share

$8.71

Shares

433,332

Total Value

$3,774,321.72

Owned After

0

SEC Form 4

Latest Exicure Inc. News

XCUR Breaking Stock News: Dive into XCUR Ticker-Specific Updates for Smart Investing

All XCUR News

Share on Social Networks: